Immunomodulating Anticancer Alkylating Drugs: Targets and Mechanisms of Activity
Journal:
Current Drug Targets
Volume:
2
Page:
197-212
Author(s):
S. Ben-Efraim
Molecular Analysis of Primary Central Nervous System and Primary Intraocular Lymphomas.
Journal:
Current Molecular Medicine
Volume:
1
Page:
259-272
Author(s):
N. Tuaillon and C. C. Chan
Structure-Activity Relationships of Multidrug Resistance Reversers
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
685-713
Author(s):
Michael Wiese and Ilza K. Pajeva
Carbonic Anhydrase Inhibitors
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
61-97
Author(s):
Claudiu T. Supuran and Andrea Scozzafava
Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells
Journal:
Current Drug Targets
Volume:
2
Page:
57-77
Author(s):
Alexander A. Shtil
Preface
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
i-i
Author(s):
Alain Rolland
Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
19-46
Author(s):
Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter
SUBJECT INDEX TO VOLUME 1
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
115-118
Author(s):
The Mouse In Cancer Research Past, Present, Future
Journal:
Current Genomics
Volume:
2
Page:
1-26
Author(s):
K. Hunter and D. Cozma
Bestatin as an Experimental Tool in Mammals
Journal:
Current Drug Metabolism
Volume:
2
Page:
67-85
Author(s):
O. A. Scornik and V. Botbol